Saint Lazare, Canada

Francois Denis

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francois Denis. Retrieved from https://idiyas.com/inventor/francois-denis-in64ul6n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Francois Denis

Introduction

Francois Denis is an accomplished inventor based in St-Lazare, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for kidney diseases.

Latest Patents

Francois Denis holds 2 patents. His latest patents include "Inhibitors of APOL1 and methods of using same." This disclosure provides at least one compound, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of formula (I), deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing. The compositions comprising the same, and methods of making and using the same, include use in treating APOL1 mediated kidney disease.

Career Highlights

Francois is currently employed at Vertex Pharmaceuticals, Inc., where he continues to innovate and contribute to the advancement of medical science. His work focuses on developing effective treatments that can significantly improve patient outcomes.

Collaborations

Francois has collaborated with notable colleagues, including Leslie A Dakin and Timothy J Senter. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Francois Denis is a notable inventor whose work in the pharmaceutical industry has the potential to impact the treatment of kidney diseases significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…